NCT03046082

Brief Summary

Observation of prescription usage of anaerobic antibiotics for patients admitted to the ICU with pneumonia.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
192

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2016

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2016

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

February 6, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 8, 2017

Completed
Last Updated

November 30, 2023

Status Verified

November 1, 2023

Enrollment Period

4 months

First QC Date

February 6, 2017

Last Update Submit

November 28, 2023

Conditions

Pneumonia

Outcome Measures

Primary Outcomes (1)

  • Usage of anaerobic antibiotics

    Percent of patients receiving inappropriate anaerobic antibiotics

    6 months

Interventions

AntibioticsDRUG

Observation of antibiotic types given to patients with pneumonia.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients admitted to the intensive care unit with a diagnosis of pneumonia.

You may qualify if:

  • ICU patients with diagnosis of pneumonia

You may not qualify if:

  • patients with abdominal infections such as c diff.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pneumonia

Interventions

Anti-Bacterial Agents

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Anti-Infective AgentsTherapeutic UsesPharmacologic ActionsChemical Actions and Uses

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Staff Physician

Study Record Dates

First Submitted

February 6, 2017

First Posted

February 8, 2017

Study Start

January 1, 2016

Primary Completion

May 1, 2016

Study Completion

May 1, 2016

Last Updated

November 30, 2023

Record last verified: 2023-11